Capula Management’s Idexx Laboratories IDXX Stock Holding History

Capula Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$62.4K	Buy	+111	New	+$71.2K	﹤0.01%	965
2023 Q3	–	Sell	-660	Closed	-$331K	–	582
2023 Q2	$331K	Sell	660 -419	-39%	-$201K	0.01%	355
2023 Q1	$540K	Sell	1,079 -97	-8%	-$46.4K	0.01%	405
2022 Q4	$480K	Sell	1,176 -1,724	-59%	-$669K	0.01%	589
2022 Q3	$945K	Buy	+2,900	New	+$1.07M	0.01%	410
2021 Q3	–	Sell	-626	Closed	-$395K	–	950
2021 Q2	$395K	Buy	+626	New	+$346K	0.01%	514

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capula Management's IDXX Position: Q1 2026 in Review

Capula Management opened a new position in Idexx Laboratories (IDXX) in Q1 2026: 111 shares worth $62.4K. The stake represents ﹤0.01% of the portfolio and ranks #965 among its holdings. This is a return to the name: Capula Management previously reported a position in IDXX as recently as Q2 2023.

Capula Management first reported a position in IDXX in Q2 2021 and has held it in 6 quarters since. The position peaked at $945K in Q3 2022. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Capula Management held 111 shares of Idexx Laboratories worth $62.4K as of Q1 2026.
Idexx Laboratories was a new Capula Management position in Q1 2026.
Idexx Laboratories made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #965 holding.
Capula Management first reported a position in Idexx Laboratories in Q2 2021 and has held it in 6 quarters since.
Capula Management's Idexx Laboratories position peaked at $945K in Q3 2022.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.